Edap Tms S.A. (NASDAQ:EDAP – Get Rating) was the recipient of a significant decrease in short interest in the month of June. As of June 15th, there was short interest totalling 18,700 shares, a decrease of 61.4% from the May 31st total of 48,500 shares. Based on an average daily trading volume, of 57,800 shares, the short-interest ratio is presently 0.3 days. Approximately 0.1% of the company’s stock are short sold.
Hedge funds have recently made changes to their positions in the company. JPMorgan Chase & Co. purchased a new position in shares of Edap Tms in the first quarter valued at $60,000. Envestnet Asset Management Inc. purchased a new position in shares of Edap Tms in the fourth quarter valued at $94,000. HighTower Advisors LLC purchased a new position in shares of Edap Tms in the first quarter valued at $185,000. Camarda Financial Advisors LLC purchased a new position in shares of Edap Tms in the first quarter valued at $209,000. Finally, Allspring Global Investments Holdings LLC purchased a new stake in Edap Tms during the 1st quarter worth about $723,000. Institutional investors and hedge funds own 28.71% of the company’s stock.
Several brokerages have commented on EDAP. Piper Sandler dropped their price target on shares of Edap Tms from $13.00 to $11.00 in a research note on Wednesday, May 18th. StockNews.com began coverage on shares of Edap Tms in a research note on Thursday, March 31st. They issued a “hold” rating on the stock.
Edap Tms (NASDAQ:EDAP – Get Rating) last issued its quarterly earnings results on Tuesday, May 17th. The medical equipment provider reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.02. Edap Tms had a return on equity of 0.44% and a net margin of 0.47%. The firm had revenue of $14.53 million during the quarter, compared to the consensus estimate of $12.96 million. During the same period last year, the company earned $0.03 earnings per share. Equities research analysts predict that Edap Tms will post -0.08 earnings per share for the current year.
Edap Tms Company Profile (Get Rating)
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST).
- Get a free copy of the StockNews.com research report on Edap Tms (EDAP)
- Schnitzer Steel Witnesses A Strong Quarter On The Back Of Strong Domestic Demand
- MarketBeat: Week in Review 6/27 – 7/1
- Accolade Moves Higher But Growth Is Slowing
- ZIM Integrated Shipping Services (ZIM): Don’t Miss This Dividend
- RH Gives Good Reason To Get Defensive
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.